Prevention

Rapid assessment study findings reveal challenging conditions for people who use and inject drugs in Ghana coupled with a relatively high prevalence of HIV and hepatitis C compared to the general population. More

A study performed a novel genetic analysis of hepatitis C virus transmission networks among people who inject drugs in Kenya. More

Researchers from Canada and Australia sought to assess the return on investment for Canada’s prison needle exchange programs, and the potential impact of scaling it up, as part of efforts to eliminate blood-borne infections in prisons. More

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study More

A study assessed risk factors, prevalence, and trends of active HCV infection among people experiencing homelessness in Madrid, Spain (2019-2023). More

Researchers in Quebec have been surveying nearly 16,000 people who inject drugs; Between 1995 and 2020 they found decreases in HIV infections and sharing of drug equipment; However, rates of exposure to hepatitis C virus did not decrease as much. More

Unlike many European countries that have abandoned needle and syringe exchange programs for inmates, Moldova has continued to press ahead with innovative prison reforms aimed at reducing the spread of diseases like HIV and hepatitis B and C. More

HCV prevalence and phylogenetic characteristics in a cross‐sectional, community study of young people who inject drugs in New York City: Opportunity for and threats to HCV elimination More

A study details the significant transformations in harm reduction services across Europe during the COVID-19 pandemic. More

Among PWID treated for hepatitis C, rates of reinfection were high soon after sustained virologic response but decreased with longer follow-up, according to a secondary analysis of the randomized HERO trial. More